Document is current
Any future updates will be listed below
-
Authors
Sun, Houyi
Zhai, Haoxin
Han, Kaifei
Ma, Heran
Tan, Yi
Li, Shihao
Liu, Zhicheng
Cheng, Lei
Lu, Qunshan
Zhou, Libo
Liu, Peilai https://orcid.org/0000-0002-2661-8496
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82302699, 82472424)
China Postdoctoral Science Foundation (2023M732099)
- License Information
-
More Information
Article History
Received: 19 June 2024
Accepted: 29 October 2024
First Online: 18 November 2024
Declarations
:
: This clinical study was a prospective, randomized, open-label, blind end point trial conducted at a single institution. The project was approved by the Ethics Committee of Qilu Hospital of Shandong University (approval number: 2018-023) with the title “Effectiveness of Autologous Adipose-derived Stem Cells in the Treatment of Knee Cartilage Injury” on August 1st, 2018. The study was registered on the U.S. National Institutes of Health sponsored website, , under the identification number, NCT03955497, before any subjects were enrolled. Informed consent was obtained from all the subjects prior to active participation in the study.
: Informed consent was obtained from all the subjects prior to active participation in the study.
: The authors declare that they have no competing interests.
